Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.
Novo Nordisk Shares Surge on New Obesity Drug Results
Breaking news
Editor Picks
Must read
Popular this week
National
Copyrights 2020 CBNC.com - All rights reserved